Home › Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of...
 

Keywords :   


Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of...

2016-03-09 05:27:50| Biotech - Topix.net

Expected Toxicity of Claimed Immunoconjugates Thwarts Showing of Prima Facie Obviousness ) In an inter partes review proceeding, the Patent Trial and Appeal Board upheld the patentability of Phigenix's patent claims that were challenged on the basis of obviousness. Phigenix, Inc. v.

Tags: of showing expected claimed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.11Spain fines budget airlines including Ryanair 179m
22.11Eastern North Pacific Tropical Weather Outlook
22.11Atlantic Tropical Weather Outlook
22.11Rush PANTS
22.11SBS
22.11/
22.11 YOU
22.11
More »